Learn more. Schedule a meeting your local Business Development Manager today!
BioIVT understands your research needs for high-quality biospecimens – that’s why our donor centers are strategically located at biotech hubs throughout the world.
To better serve you, we have officially moved to London’s biotechnology hub in White City! Your research needs fresh material, and we are now better poised to bring you just that. The new donor center has quadruple the floor space and longer donation hours for increased collection capacity.
As if that were not enough, our new location means we can now do on-site immune cell isolation! With this service, we help you maximize your research time in the laboratory. Our immune cell capabilities are unmatched with high-definition HLA haplotyping, Fc Receptor genotyping, and donor CMV status testing. Browse our ready-to-ship inventory of immune cells.
We also offer Point-of-Care (POC) device services, where we will operationalize your protocol to bring your POC device
to life. We can recruit specific cohorts for your individual POC testing needs –
including cardiovascular diseases, endocrine/metabolic disorders, infectious diseases and others.
For more information, download
our information sheet or visit our
POC Testing Services page.
![]() |
Red Blood Cell Contaminants: Upstream Mitigation for Downstream Success Download this white paper to find out how LEUKOMAX® apheresis products or purified immune cell subsets can optimize your workflow. |
![]() |
Isolation of Tumor-Infiltrating Lymphocytes from Dissociate Tumor Cells Developing solid tumor cell therapies with tumor-infiltrating lymphocytes (TILs)? Download this white paper to learn how Dissociated Tumor Cell (DTC) products can be an excellent source of TILs. |
![]()
|
ImmunoEconomics: Financial Considerations for In-House Manual Cell Isolation Versus Cryopreserved Cell Products Quality research always involves the right balance of cost, time and risk. Download our white paper and learn the process economics, cost-benefit and scalability of using purified immune cell subsets. |